Metformin Inhibits Hepatic Gluconeogenesis Through AMP-Activated Protein Kinase–Dependent Regulation of the Orphan Nuclear Receptor SHP
Diabetes2007Vol. 57(2), pp. 306–314
Citations Over TimeTop 10% of 2007 papers
Yong Deuk Kim, Keun‐Gyu Park, Yong‐Soo Lee, Yun‐Yong Park, Don‐Kyu Kim, Balachandar Nedumaran, Won Gu Jang, Won‐Jea Cho, Joohun Ha, In‐Kyu Lee, Chul‐Ho Lee, Hueng-Sik Choi
Abstract
We have concluded that metformin inhibits hepatic gluconeogenesis through AMPK-dependent regulation of SHP.
Related Papers
- → Cytosolic Phosphoenolpyruvate Carboxykinase Does Not Solely Control the Rate of Hepatic Gluconeogenesis in the Intact Mouse Liver(2007)275 cited
- → TWO CASES OF PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY(1976)70 cited
- → The Synthesis of Phosphoenolpyruvate in the Gluconeogenesis(1967)24 cited
- → Compartmentation of Liver Phosphoenolpyruvate Carboxykinase in the Aquatic Turtle Pseudemys Scripta Elegans: A Reassessment(1993)2 cited
- → Relationship of Mitochondrial Phosphoenolpyruvate Carboxykinase to Neonatal Gluconeogenesis(1981)3 cited